Health Information Encyclopedia Health Information Encyclopedia Health Information Encyclopedia
Health Information
Health Information Encyclopedia


Health Information Health Information Encyclopedia Health Information Encyclopedia
Health Information Encyclopedia Health Information
Health Encyclopedia Health Information Encyclopedia Health Information
Health Information Health Information Health Information
Health Encyclopedia Health
Health Health Health
medical medicine medicine
Health Health Information Encyclopedia
Health Information Encyclopedia Health Encyclopedia Health
 

NEURAL TUBE DEFECTS ETIOLOGY

Category: Child Health
Abstract : ETIOLOGY Over the last century, teratogens implicated in the etiology of NTD in experimental animals and in humans include potato blight, hyperthermia, low economic status, antihistamine and sulfonamide use, nutritional deficiencies, vitamin deficiencies, and anticonvulsant use. Of all the suspected teratogens, carbamazepine, valproic acid, and folate deficiency have been most strongly

ETIOLOGY
Over the last century, teratogens implicated in the etiology of NTD in experimental animals and in humans include potato blight, hyperthermia, low economic status, antihistamine and sulfonamide use, nutritional deficiencies, vitamin deficiencies, and anticonvulsant use. Of all the suspected teratogens, carbamazepine, valproic acid, and folate deficiency have been most strongly tied to the development of NTD.

In humans, carbamazepine and valproic acid have been definitively identified as teratogens. Valproic acid is a known folate antagonist and may work through that action. A woman taking valproic acid during pregnancy has an estimated risk of 1-2% of having a child with an NTD. Therefore, women taking antiepileptic drugs during pregnancy are advised to undergo routine prenatal screening with AFP.

Smithells first advanced the concept that nutrition may be related to the development of NTD in the 1970s. He noted that a low erythrocyte folate and leukocyte ascorbic acid during the first trimester resulted in more pregnancies affected by NTDs than in controls. His early work led to 2 important randomized controlled studies on the use of periconception folate by British and Hungarian research groups.

The Medical Research Council in Britain performed a prospective, randomized, double-blind, multicenter trial to see if women who previously gave birth to children with NTDs could lower the recurrence rate with multivitamins or folate (4 mg/d). Thus, 1817 women who had had a previous child with an NTD and 1195 women who had not were randomized into 4 groups. One group received multivitamins, another group received folate, the third group received both, and the fourth group received neither. The study was terminated early when a significant protective effect was observed in the groups that received folic acid but not in the groups that did not. Multivitamins alone had no significant protective effect. Folic acid ingestion in the preconception period prevented an estimated 72% of recurrent NTDs. The article with this conclusion was published in Lancet in 1991.

Hungarian investigators performed a randomized, double-blind, multicenter trial of folic acid to see if it had a protective effect for a first occurrence of NTD. One group of 2104 women received 0.8 mg of folic acid with their multivitamins, while the second group of 2052 women received no folic acid with their multivitamins. The folic acid group had no cases of NTD, while the non–folic-acid group had 6 cases. This finding, published in the New England Journal of Medicine in 1992, indicated that ingestion of preconception folic acid significantly decreased the first occurrence of NTD. For this reason, the US Public Health Service issued their strongly worded recommendation to women of childbearing age to take folic acid supplements.

However, several important issues have been raised. Since only 50% or fewer of the pregnancies in the United States are planned, compliance with the request to ingest preconception folic acid is not always easy to achieve. Folic acid is not protective unless ingested in the periconception period. The NTD occurs before day 26 postfertilization, often before many women have discovered their pregnancy. The precise minimal dose of folate required to be protective against an NTD has not been determined, thus making routine food fortification a difficult issue. Furthermore, folic acid can mask a vitamin B-12 deficiency that can cause neurologic damage. For these reasons, ingesting daily folic acid in the form of a multivitamin tablet has become the preferred recommendation. Finally, the precise mechanism in which folic acid is protective is unclear.

Hit: 331 times

Related Articles in Child Health :
neural tube defects etiology
neural tube defects etiology
neural tube defects etiology
neural tube defects etiology
neural tube defects etiology neural tube defects etiology neural tube defects etiology